Cargando…
A Comparative Pharmacokinetics Study of the Anti-Parkinsonian Drug Pramipexole
The present study aimed to compare pharmacokinetic parameters of two pramipexole 0.25 mg formulations in order to show bioequivalence. The study was conducted in a randomized, open-label, two-period, two-sequence, and crossover design, involving 23 healthy volunteers. One of the 0.25 mg formulations...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5198030/ https://www.ncbi.nlm.nih.gov/pubmed/27869754 http://dx.doi.org/10.3390/scipharm84040715 |